Amedisys Inc. (AMED)
NASDAQ: AMED
· Real-Time Price · USD
100.99
0.01 (0.01%)
At close: Aug 14, 2025, 3:59 PM
0.01% (1D)
| Bid | 99.01 |
| Market Cap | 3.32B |
| Revenue (ttm) | 2.4B |
| Net Income (ttm) | 149.69M |
| EPS (ttm) | 2.57 |
| PE Ratio (ttm) | 39.295719844357976 |
| Forward PE | 19.53 |
| Analyst | Hold |
| Ask | 102 |
| Volume | 1,037,740 |
| Avg. Volume (20D) | 517,900 |
| Open | 101.00 |
| Previous Close | 100.98 |
| Day's Range | 100.93 - 101.02 |
| 52-Week Range | 82.15 - 101.02 |
| Beta | 0.90 |
About AMED
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMED
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMED stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Amedisys has released their quartely earnings
on Jul 29, 2025:
Next Earnings Release
Amedisys Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+4.67%
Amedisys shares are trading higher after the compa...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying FactorsAMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it f...
1 month ago · fool.com
Amedisys (AMED) Q2 Revenue Tops 5%Amedisys (AMED) Q2 Revenue Tops 5%
